Notice of Special Interest (NOSI): Maximizing the Scientific Value of Secondary Analyses of Existing Cohorts and Datasets in Order to Address Research Gaps and Foster Additional Opportunities in Aging Research

The goal of this Notice of Special Interest (NOSI) is to encourage the use of existing cohorts and datasets for well-focused secondary analyses to investigate novel scientific ideas and/or address […]
Read More

Dementia Care and Caregiver Support Intervention Research (R01 Clinical Trial Required)

This Funding Opportunity Announcement (FOA) solicits mechanism-focused dementia care and caregiver support intervention development research at Stages I through V of the NIH Stage Model to address the care needs and […]
Read More

NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed)

The objectives of the NIH Academic Leadership Career Award (K07) are to increase the pool of individuals with academic and research expertise in a specific area of biomedical research and […]
Read More

NIA IMPACT Collaboratory – Career Development Award

These CDAs seek to support the development of early-stage MD, PhD, or equivalent researchers who seek careers conducting ePCTs for people living with AD/ADRD and their care partners. The IMPACT […]
Read More

The Midlife in the United States Study – Cognitive and Neurocognitive Precursors of AD/ADRD (U01 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to solicit an Alzheimer’s disease and Alzheimer’s disease related dementias (AD/ADRD)-focused U01 that is ancillary to, but integrated with, the Midlife […]
Read More

The Midlife in the United States Study – Cognitive and Neurocognitive Precursors of AD/ADRD (U01 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to solicit an Alzheimer’s disease and Alzheimer’s disease related dementias (AD/ADRD)-focused U01 that is ancillary to, but integrated with, the Midlife […]
Read More

Alzheimer’s Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required)

This Funding Opportunity Announcement (FOA) invites applications to develop and implement Phase Ib to III clinical trials of promising pharmacological and non-pharmacological interventions that may prevent, delay, or treat the […]
Read More

Notice of Change in Application Types Allowed for PAR-19-071 Research on Current Topics in Alzheimer’s Disease and Its Related Dementias (R21 Clinical Trial Not Allowed)

This Notice informs potential applicants that the application types allowed in response to PAR-19-071 Research on Current Topics in Alzheimer’s Disease and Its Related Dementias (R01 Clinical Trial Not Allowed) […]
Read More

Notice of Change in Application Types Allowed for PAR-19-070 Research on Current Topics in Alzheimer’s Disease and Its Related Dementias (R01 Clinical Trial Optional)

This Notice informs potential applicants that the application types allowed in response to PAR-19-070 Research on Current Topics in Alzheimer’s Disease and Its Related Dementias (R01 Clinical Trial Optional) have […]
Read More

Alzheimer’s Disease Sequencing Project Functional Genomics Consortium (U01 Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) supports concerted efforts that take a multipronged, team-science strategy and apply high-throughput, genome-wide approaches to systematically discover and characterize functional genomic and epigenomic elements and […]
Read More